Literature DB >> 7612304

The C-S lysis of L-cysteine conjugates by aspartate and alanine aminotransferase enzymes.

P J Gaskin1, H J Adcock, L D Buckberry, P H Teesdale-Spittle, P N Shaw.   

Abstract

One biotransformation pathway which is responsible for the generation of mutagenic and cytotoxic metabolites is that of the C-S lysis (CSL) of L-cysteine conjugates. Thirteen cysteine S-conjugates, synthesised in our laboratories, were incubated with porcine heart aspartate aminotransferase (ASAT) and alanine aminotransferase (ALAT), and the C-S lyase activity for each enzyme-substrate combination was determined. ASAT and ALAT were shown to exhibit CSL activity. It was also demonstrated that this activity was inhibited in the presence of the pyridoxal phosphate (PLP)-dependent enzyme inhibitor amino(oxyacetic acid) (AOAA) confirming the pyridoxal phosphate dependent mechanism by which C-S lysis is known to take place. Since the activities of these enzymes are used as biomarkers for the assessment of organ damage, the potential interaction of L-cysteine conjugates with them may suppress their activity through direct inhibition.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7612304     DOI: 10.1177/096032719501400506

Source DB:  PubMed          Journal:  Hum Exp Toxicol        ISSN: 0960-3271            Impact factor:   2.903


  2 in total

1.  Mitochondrial aspartate aminotransferase catalyses cysteine S-conjugate beta-lyase reactions.

Authors:  Arthur J L Cooper; Sam A Bruschi; Ana Iriarte; Marino Martinez-Carrion
Journal:  Biochem J       Date:  2002-11-15       Impact factor: 3.857

2.  Cisplatin nephrotoxicity: molecular mechanisms.

Authors:  Marie H Hanigan; Prasad Devarajan
Journal:  Cancer Ther       Date:  2003
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.